BBH vs. PBE
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and Invesco Dynamic Biotechnology & Genome ETF (PBE).
BBH and PBE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. PBE is a passively managed fund by Invesco that tracks the performance of the Dynamic Biotech & Genome Intellidex Index (AMEX). It was launched on Jun 23, 2005. Both BBH and PBE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBH or PBE.
Correlation
The correlation between BBH and PBE is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BBH vs. PBE - Performance Comparison
Key characteristics
BBH:
0.15
PBE:
0.32
BBH:
0.32
PBE:
0.56
BBH:
1.04
PBE:
1.07
BBH:
0.08
PBE:
0.20
BBH:
0.40
PBE:
1.22
BBH:
6.25%
PBE:
4.74%
BBH:
16.62%
PBE:
18.04%
BBH:
-72.69%
PBE:
-45.69%
BBH:
-24.00%
PBE:
-18.38%
Returns By Period
In the year-to-date period, BBH achieves a 4.88% return, which is significantly higher than PBE's 2.75% return. Over the past 10 years, BBH has outperformed PBE with an annualized return of 2.98%, while PBE has yielded a comparatively lower 2.43% annualized return.
BBH
4.88%
1.62%
-8.22%
2.54%
3.08%
2.98%
PBE
2.75%
-1.04%
-3.16%
7.55%
4.13%
2.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. PBE - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than PBE's 0.59% expense ratio.
Risk-Adjusted Performance
BBH vs. PBE — Risk-Adjusted Performance Rank
BBH
PBE
BBH vs. PBE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBH vs. PBE - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.76%, more than PBE's 0.05% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.76% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% | 0.00% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.05% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% | 0.55% |
Drawdowns
BBH vs. PBE - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.69%, which is greater than PBE's maximum drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for BBH and PBE. For additional features, visit the drawdowns tool.
Volatility
BBH vs. PBE - Volatility Comparison
VanEck Vectors Biotech ETF (BBH) has a higher volatility of 5.31% compared to Invesco Dynamic Biotechnology & Genome ETF (PBE) at 4.21%. This indicates that BBH's price experiences larger fluctuations and is considered to be riskier than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.